Status:
RECRUITING
Artificial Intelligence System for Early Warning of Adverse Events in Acute Myocardial Infarction
Lead Sponsor:
Hui Chen
Conditions:
Acute Myocardial Infarction With ST Elevation
Intelligent Management Platform
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to learn about the effectiveness of an artificial intelligence-based early warning system for predicting adverse events in patients with acute myocardial infarc...
Eligibility Criteria
Inclusion
- 1\. Hospitalized patients who meet the diagnostic criteria for acute myocardial infarction. 2. Patients who agree to participate and sign the informed consent form.
Exclusion
- 1\. Patients with terminal malignant tumors and an expected survival time of less than 3 months. 2. Patients with complete disability and inability to communicate. 3. Patients unable to comply with follow-up.
Key Trial Info
Start Date :
November 26 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
1400 Patients enrolled
Trial Details
Trial ID
NCT07139860
Start Date
November 26 2022
End Date
December 31 2026
Last Update
August 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Friendship Hospital
Beijing, China, 100050